NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Exactly... as others have also pointed out, if the company suspects an approval is forthcoming, then having this report already on hand to educate potential new investors (retail and/or funds) would be very helpful. If you suspect the opposite (like you're fighting a negative CHM recommendation), you'd likely not commission a report that educated the reader on what to expect with an MHRA approval, lol.

:)